Clinical Trials Browser

Phase 2 × OTHER × Disease × Clear all

NCT07223385 2026-05-04

High Cardiovascular Risk Intervention With Cardio-Oncology Consultation for Prostate Cancer Following Androgen Receptor Pathway Inhibitor (ARPI) Therapy (Heart-Safe)

Phase 2 Not yet recruiting

Disease, Prostatic Neoplasms

NCT07549451 2026-04-24

Phase 2 Study Of Imetelstat for Patient With Myelodysplastic/Myeloproliferative Neoplasms

Phase 2 Not yet recruiting

Disease

NCT07299292 2025-12-23

Castration With Abiraterone 250 mg Without LHRH Analogs or Blockers in Patients With Prostate Cancer Requiring Hormonal Intensification (Multicenter Phase 2)

Phase 2 Recruiting

Disease, Prostatic Neoplasms

NCT03728972 2025-10-23

Study of Pembrolizumab in Patients With Early-Stage NK/T-cell Lymphoma, Nasal Type

Phase 2 Active not recruiting

19 enrolled 9 charts

Disease

NCT07134101 2025-08-29

SMARTi-RC01

Phase 2 Not yet recruiting

Gastrointestinal

Disease, Colorectal Neoplasms

NCT04965454 2025-05-01

ExTRACT-HCC

Phase 2 Recruiting

Gastrointestinal

Disease, Carcinoma, Hepatocellular

NCT06667973 2025-03-12

Efficacy of Gilteritinib in Combination With FLAI as Induction Therapy of FLT3-positive Acute Myeloid Leukemia

Phase 2 Not yet recruiting

Other hematologic neoplasm

Disease, Leukemia, Myeloid, Acute

NCT04775602 2025-01-09

F-PSMA

Phase 2 Completed

Disease, Prostatic Neoplasms

NCT01160107 2023-06-29

RP_MPR

Phase 2 Completed

Disease, Multiple Myeloma

NCT00128856 2023-03-06

Gemcitabine, Doxorubicin and Paclitaxel (GAT) as Neoadjuvant Treatment of Breast Cancer Patients

Phase 2 Completed

Breast Neoplasms, Disease

NCT01613300 2021-05-26

Study of OFATUMUMAB as Part of the Scheme of Reduced Intensity Conditioning in High Risk Non-Hodgkin Lymphoma B Patients

Phase 2 Completed

Disease, Lymphoma, B-Cell

NCT03755947 2021-02-02

Ibrutinib, Obinutuzumab and Venetoclax for Patients With Chronic Lymphocytic Leukemia

Phase 2 Completed

LymphoidOther hematologic neoplasm

Disease, Leukemia, Lymphocytic, Chronic, B-Cell

NCT01262027 2019-07-30

TKI258 for Metastatic Inflammatory Breast Cancer Patients

Phase 2 Completed

22 enrolled 7 charts

Breast Neoplasms, Disease, Inflammatory Breast Neoplasms

NCT03185182 2019-06-21

RCCSCAN

Phase 2 Terminated

5 enrolled 5 charts

Carcinoma, Renal Cell, Disease

NCT02971319 2018-01-26

Technical Performance Assessment of Tc-99m Tetrofosmin for Differentiation of Recurrence vs Radiation Necrosis in Patients With Glioma

Phase 2 Completed

Disease, Glioma

NCT02468050 2015-06-10

Study of Exercise to Manage Distress During Breast Screening

Phase 2 Completed

Anxiety Disorders, Breast Neoplasms, Depression, Disease, Motor Activity

NCT00784849 2012-06-20

Feasibility of One-Step Sentinel Lymph Node (SLN) Biopsy With Radiolabeled Methylene Blue (IND 70,627)

Phase 2 Completed

62 enrolled 5 charts

Breast Neoplasms, Disease

NCT00224601 2011-02-18

CHROENDOHNPCC: Early Detection of Pre-cancer Lesions in Adults With Hereditary Nonpolyposis Colorectal Cancer Syndrome

Phase 2 Completed

Gastrointestinal

Colorectal Neoplasms, Hereditary Nonpolyposis, Disease, Colorectal Neoplasms

NCT00143975 2010-08-12

Gemtuzumab Ozogamicin in Combination With A-HAM in Refractory AML (GO-A-HAM)

Phase 2 Completed

Other hematologic neoplasm

Disease, Leukemia, Myeloid, Acute

NCT00660283 2010-01-20

KARE003

Phase 2 Unknown

Disease, Glioma

NCT00712621 2009-11-24

Determining Quality of Life in Breast Cancer Patient After Completing Radiation,Chemotherapy,Surgery or Combination

Phase 2 Withdrawn

Breast Neoplasms, Disease